Sanjay K. Shrestha, Chief Executive Officer and Director of Health In Tech, Inc. (NASDAQ:HIT), filed a Form 4 on November 13, 2026, disclosing the acquisition of 2,500,000 restricted shares of Class A Common Stock on November 10, 2026, at a price of $0 per share, contingent on market capitalization milestones.

Key Highlights

  • Three tranches acquired: Shrestha received 1,500,000 shares (MC-2 Tranche), 500,000 shares (MC-3 Tranche), and 500,000 shares (MC-4 Tranche) on November 10, 2026, each at $0 per share.
  • Stockholder approval triggered grants: All three tranches became effective upon stockholder approval of an amendment to the Health In Tech, Inc. Equity Incentive Plan at the issuer's 2026 Annual Meeting of Stockholders on November 10, 2026.
  • Market cap thresholds required: The MC-2, MC-3, and MC-4 Tranches require the issuer's 10-day volume-weighted average price-based market capitalization to exceed $300 million, $500 million, and $1 billion, respectively, by their respective deadlines, or shares are automatically forfeited without consideration.
  • Deadlines differ by tranche: Achievement dates are December 31, 2028 for the MC-2 Tranche, December 31, 2029 for the MC-3 Tranche, and December 31, 2031 for the MC-4 Tranche.
  • Post-milestone vesting schedule: Following each achievement date, shares vest in twelve equal monthly installments, subject to continued service.
  • Total beneficial ownership: Following all three reported transactions, Shrestha directly beneficially owns 7,601,200 shares of Class A Common Stock, including 7,500,000 restricted shares and 101,200 unrestricted shares.
  • Change in Control provision: According to the filing, all unvested restricted shares held by Shrestha vest in full upon a Change in Control as defined in his Employment Agreement.

Shrestha's Market Cap-Linked Restricted Stock Awards at Health In Tech

According to the Form 4, the three tranches of restricted Class A Common Stock were granted pursuant to a Restricted Stock Award Agreement dated October 20, 2026, under the Health In Tech, Inc. Equity Incentive Plan. The grants were contingent upon, and became effective upon, stockholder approval of a plan amendment at the company's 2026 Annual Meeting of Stockholders on November 10, 2026. Each tranche was acquired at a price of $0 per share, the filing disclosed.

The filing states that shares in each tranche "will be automatically forfeited without consideration" unless the issuer's market capitalization, measured using the 10-day volume-weighted average price, exceeds its respective threshold by the applicable achievement date. For the MC-2 Tranche (1,500,000 shares), the threshold is $300 million by December 31, 2028. For the MC-3 Tranche (500,000 shares), the threshold is $500 million by December 31, 2029. For the MC-4 Tranche (500,000 shares), the threshold is $1 billion by December 31, 2031.

Once a threshold is met, shares in the relevant tranche vest in twelve equal monthly installments, subject to continued service. The filing also notes that the total beneficial ownership figure of 7,601,200 shares excludes 500,000 restricted shares of Class B Common Stock previously reported. The Form 4 was signed by Lori Babcock as attorney-in-fact for Sanjay Shrestha and filed on November 13, 2026.

What Was Disclosed

Sanjay K. Shrestha, CEO and Director of Health In Tech, Inc. (NASDAQ:HIT), disclosed the acquisition of 2,500,000 restricted Class A Common Stock shares across three market capitalization-contingent tranches on November 10, 2026, bringing his direct beneficial ownership to 7,601,200 Class A shares.